Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease

Coronary Artery Disease

Volumn 13, Issue 1, 2002, Pages 9-16

  Azizi, Fereidoun ^a   Rahmani, Maziar ^a   Raiszadeh, Farbod ^a   Solati, Mehrdad ^a   Navab, Mohammad ^a  

^a NONE   (Iran)

Author keywords

Apolipoprotein; Coronary artery disease; Lipoprotein; Paraoxonase

Indexed keywords

4 NITROPHENOL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARAOXON; PHENOL; PHENYLACETIC ACID; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; ENZYME ACTIVITY; ETHNIC DIFFERENCE; FEMALE; HUMAN; IRAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TURBIDIMETRY;

ADULT; AGED; APOLIPOPROTEINS; APOLIPOPROTEINS B; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; ESTERASES; FEMALE; HUMANS; IRAN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0036206316     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200202000-00002     Document Type: Article

References (64)

1. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
2. Priorities in cardiovascular prevention in Iran
3. Prevalence of arterial hypertension in Bushehr port
4. Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesterol levels
5. The role of lipids and blood pressure in the development of coronary heart disease. The Framingham study
6. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
7. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention Trial
8. Total cholesterol and lipoproteins in school children: Prediction of coronary heart disease in adult relatives
9. Multiple risk functions for predicting coronary heart disease: The concept, accuracy, and application
10. Serum cholesterol and mortality: The Yugoslavia Cardiovascular Disease study
11. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
12. Low-density lipoproteins and risk for coronary artery disease
13. Atherosclerosis
14. The antiatherogenic role of high-density lipoprotein cholesterol
15. The trend of coronary heart disease and its risk factors based on epidemiological investigations
16. A collaborative study of stroke incidence in Japan: 1975-1979
17. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations
18. Coronary risk prediction in adults
19. Low-density and high-density lipoprotein subspecies and risk for premature coronary artery disease
20. Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction
21. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS study. European Atherosclerosis Research Study
22. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease
23. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
24. Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients
25. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease
26. Prevalence of risk factors in men with premature coronary artery disease
27. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture
28. Human serum paraoxonase
29. Paraoxonase genes and disease
30. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus
31. Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins
32. Myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus
33. Mutations in the human paraoxonase 1 gene: Frequencies, allelic linkages, and association with coronary artery disease
34. Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease
35. Apoproteins and lipids as discriminators of severity of coronary heart disease
36. Discriminative value of lipids and apoproteins in coronary heart disease
37. Mild hypercholesterolemia and premature heart disease: Do the national criteria underestimate disease risk?
38. Familial hypoalphalipoproteinemia in premature coronary artery disease
39. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease
40. Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease
41. Plasma apolipoprotein B levels predict platelet-dependent thrombosis in patients with coronary artery disease
42. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
43. High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol
44. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: A study in familial combined hyperlipidemia
45. Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: The significance of apolipoprotein B to apolipoprotein all ratio
46. Apolipoprotein concentrations during treatment and recurrent coronary artery disease events
47. Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels
48. Primary prevention of coronary heart disease: Guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on risk reduction
49. Myocardial infarction in the young. Angiographic features and risk factor analysis of patients with myocardial infarction at or before the age of 35 years
50. Myocardial infarction in young men. Study of risk factors in nine countries
51. The prevalence of coronary artery disease in an urban population in Isfahan, Iran
52. Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan
53. Relationship between classic risk factors plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran
54. Hyperlipidemia in coronary heart disease. Lipid levels in 500 survivors of myocardial infarction
55. Family study of serum lipids and lipoproteins in coronary heart-disease
56. Familial aggregation and early expression of hyperapobetalipoproteinemia
57. Association of coronary atheresclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]
58. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atheresclerosis
59. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361 662 men
60. Serum apolipoproteins Al and B and lipoproteins in middle aged men with and without previous myocardial infarction
61. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis
62. Apolipoproteins and coronary artery disease
63. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
64. Interethnic differences of human serum paraoxonase activity-relevance for the detoxification of organophosphorous compounds